Platelets dual-labeled with iron oxide nanoparticles (for photothermal therapy) and anti-PD-L1 antibodies achieved synergistic tumor control and enhanced CD4+ and CD8+ T-cell infiltration following surgical removal of residual disease [138]. This evidence concerns the gene CD4 and neoplasm.